Atlas Trials

Effectiveness and Safety of Mesenchymal Stem Cell Therapy in Long COVID Patients

Clinical trial NCT06492798 · RECRUITING

Trial details

NCT number
NCT06492798
Sponsor
Changhai Hospital
Status
RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Long COVIDPost-Acute COVID-19 Syndrome
Start date
2023-09-01
Primary completion
2025-07-01
Enrollment
76

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.